Feedback
  • Article / Essay
  • Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms…

Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting

Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Qiang, Min;
Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Chen, Zhe;
Affiliation
College of Clinical Medicine ,Jilin University ,Changchun ,China
Liu, Hongyang;
Affiliation
Department of Molecular Biology ,Max Planck Institute for Infection Biology ,Berlin ,Germany
Dong, Junxue;
Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Gong, Kejian;
Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Zhang, Xinjun;
Affiliation
Laboratory of Infection Oncology ,Institute of Clinical Molecular Biology ,Christian-Albrechts-Universität zu Kiel and University Hospital Schleswig-Holstein ,Kiel ,Germany
Huo, Peng;
Affiliation
Department of Thoracic and Cardiovascular Surgery ,Severance Hospital ,Yonsei University College of Medicine ,Seoul ,Republic of Korea
Zhu, Jingjun;
Affiliation
Department of General Surgery ,Capital Institute of Pediatrics’ Children’s Hospital ,Beijing ,China
Shao, Yifeng;
Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Ma, Jinazun;
Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Zhang, Bowei;
Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Liu, Wei;
Affiliation
Department of Thoracic Surgery ,The First Hospital of Jilin University ,Changchun ,China
Tang, Mingbo

Preview

Category

Published in:
Frontiers in Pharmacology  
Vol. 16 (24.04.2025)
Volume:
16
Date Issued:
24.04.2025
DOI:
10.3389/fphar.2025.1591443
Language:
English
Type of Resource:
Text
Keywords:
PI3K/Akt/mTOR pathway; lung cancer; PI3K inhibitors; Akt inhibitors; mTOR inhibitors; natural products; combined therapy
DDC:
610 Medizin und Gesundheit

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2025 Qiang, Chen, Liu, Dong, Gong, Zhang, Huo, Zhu, Shao, Ma, Zhang, Liu and Tang.

Use and reproduction: